Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sinovac Announces Re-Election of All Directors at Annual General Meeting 2018-03-06 05:31
Sinovac Provides Update on Going Private Transaction 2018-02-07 21:50
Sinovac Holds 2017 Annual General Meeting of Shareholders 2018-02-07 21:48
Sinovac Schedules 2017 Annual Meeting of Shareholders 2017-12-29 19:00
Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization 2017-12-23 01:05
Sinovac Biotech Cures Nasdaq Filing Deficiency 2017-12-01 19:00
Sinovac Reports Unaudited First Half of 2017 Financial Results 2017-12-01 19:00
Sinovac Biotech Announces Update on Nasdaq Matters 2017-11-30 19:00
Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results 2017-11-23 05:30
Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel 2017-11-09 05:20
Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq 2017-11-04 04:20
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox 2017-09-25 18:00
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F 2017-08-14 18:00
UPDATE: To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-07-01 02:43
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And Their Low Price, Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-06-29 02:10
Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction 2017-06-26 21:03
Sinovac Biotech Announces Receipt of NASDAQ Letter and Delayed Filing of Annual Report on Form 20-F 2017-05-17 04:00
Sinovac Reports Announces Filing Extension for 2016 Annual Report 2017-05-01 20:00
1 2